Fri, March 10, 2017
Thu, March 9, 2017

Jami Rubin Maintained (ABBV) at Strong Buy with Increased Target to $80 on, Mar 10th, 2017

Jami Rubin of Goldman Sachs, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $74 to $80 on, Mar 10th, 2017.

Jami has made no other calls on ABBV in the last 4 months.



There is 1 other peer that has a rating on ABBV. Out of the 1 peers that are also analyzing ABBV, all agrees with Jami's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Baum of "Citigroup" Downgraded from Strong Buy to Hold on, Monday, November 28th, 2016